Frequent PIK3CA activating mutations in nipple adenomas.

作者: Jau-Yu Liau , Yi-Hsuan Lee , Jia-Huei Tsai , Chang-Tsu Yuan , Chia-Yu Chu

DOI: 10.1111/HIS.13043

关键词:

摘要: Aims Nipple adenoma (NA) is a rare benign epithelial tumour occurring in the nipple. Histologically, it exhibits variable and often mixed adenosis-like usual ductal hyperplasia-like growth patterns. Morphologically, similar to other proliferative breast lesions parenchyma, which have been shown harbour activating mutations PIK3CA, AKT1 or, less frequently, RAS more than 50% of cases. In this study, we aimed analyse mutation status AKT1, BRAF NAs correlated with histological features. Methods results Mutation analysis was performed 24 by Sanger sequencing. Our results showed that PIK3CA were identified eight 15 (53%) predominantly pattern four nine (44%) pattern. One H1047R also had KRAS Q61H mutation. Two tumours an V600E mutations. Overall, half (12 24, 50%) our series 58% (14 24) or mutations. Conclusions Our data indicate that, are very common NAs, may occur concurrently addition, as has not previous studies, BRAF-mutated appear distinct pathogenesis.

参考文章(36)
Mark Kriegsmann, Volker Endris, Thomas Wolf, Nicole Pfarr, Albrecht Stenzinger, Sibylle Loibl, Carsten Denkert, Andreas Schneeweiss, Jan Budczies, Peter Sinn, Wilko Weichert, Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences. Oncotarget. ,vol. 5, pp. 9952- 9965 ,(2014) , 10.18632/ONCOTARGET.2481
Guojun Wu, Mingzhao Xing, Elizabeth Mambo, Xin Huang, Junwei Liu, Zhongmin Guo, Aditi Chatterjee, David Goldenberg, Susanne M Gollin, Saraswati Sukumar, Barry Trink, David Sidransky, Somatic mutation and gain of copy number of PIK3CA in human breast cancer. Breast Cancer Research. ,vol. 7, pp. 1- 8 ,(2005) , 10.1186/BCR1262
Elizabeth L. Kehr, Julie M. Jorns, Daphne Ang, Andrea Warrick, Tanaya Neff, Michelle Degnin, Rebecca Lewis, Carol Beadling, Christopher L. Corless, Megan L. Troxell, Mucinous breast carcinomas lack PIK3CA and AKT1 mutations Human Pathology. ,vol. 43, pp. 2207- 2212 ,(2012) , 10.1016/J.HUMPATH.2012.03.012
B Karakas, K E Bachman, B H Park, Mutation of the PIK3CA oncogene in human cancers. British Journal of Cancer. ,vol. 94, pp. 455- 459 ,(2006) , 10.1038/SJ.BJC.6602970
Jeffrey A. Engelman, Targeting PI3K signalling in cancer: opportunities, challenges and limitations Nature Reviews Cancer. ,vol. 9, pp. 550- 562 ,(2009) , 10.1038/NRC2664
Matthew J. Ellis, Li Lin, Robert Crowder, Yu Tao, Jeremy Hoog, Jacqueline Snider, Sherri Davies, Katherine DeSchryver, Dean B. Evans, Jutta Steinseifer, Raj Bandaru, WeiHua Liu, Humphrey Gardner, Vladimir Semiglazov, Mark Watson, Kelly Hunt, John Olson, José Baselga, Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer. Breast Cancer Research and Treatment. ,vol. 119, pp. 379- 390 ,(2010) , 10.1007/S10549-009-0575-Y
Megan L Troxell, Judith Levine, Carol Beadling, Andrea Warrick, Jennifer Dunlap, Ajia Presnell, Janice Patterson, Arielle Shukla, Neal R Olson, Michael C Heinrich, Christopher L Corless, High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast. Modern Pathology. ,vol. 23, pp. 27- 37 ,(2010) , 10.1038/MODPATHOL.2009.142
Ellen Flatley, Daphne Ang, Andrea Warrick, Carol Beadling, Christopher L. Corless, Megan L. Troxell, PIK3CA-AKT pathway mutations in micropapillary breast carcinoma Human Pathology. ,vol. 44, pp. 1320- 1327 ,(2013) , 10.1016/J.HUMPATH.2012.10.018
Jau-Yu Liau, Jia-Huei Tsai, Ray-Hwang Yuan, Chih-Ning Chang, Hsin-Jung Lee, Yung-Ming Jeng, Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features Modern Pathology. ,vol. 27, pp. 1163- 1173 ,(2014) , 10.1038/MODPATHOL.2013.241